dihexa hgf c-met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF-c-Met Axis in Head – Small molecule activation of the
Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease c MET: A Key Target in Cancer Therapy Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



